Find clinical trials for Triple Negative Breast Cancer in Hanyang, Seoul

of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...

mg twice per day. Capivasertib or placebo could be interrupted for up to 4 weeks for toxicity.Tumor assessments included computed tomograph...

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...

for patients with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple...

after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The prim...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received n...

vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).After a screening ph...

with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who car...